A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas (Q33428049)

26 July 2017

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas (English)

1 reference

26 July 2017

diffuse midline glioma

0 references

1 reference

Charles Stevenson

17

0 references

Mary Sutton

Mary Sutton

11

0 references

Lionel Chow

Lionel M Chow

12

0 references

Adam Lane

Adam Lane

9

0 references

Maryam Fouladi

18

Maryam Fouladi

1 reference

26 July 2017

Trent R Hummel

1

1 reference

26 July 2017

Ralph Salloum

2

1 reference

26 July 2017

Rachid Drissi

3

1 reference

26 July 2017

Shiva Kumar

4

1 reference

26 July 2017

Matthew Sobo

5

1 reference

26 July 2017

Stewart Goldman

6

1 reference

26 July 2017

Ahna Pai

7

1 reference

26 July 2017

James Leach

8

1 reference

26 July 2017

David Pruitt

10

1 reference

26 July 2017

Laurie Grimme

13

1 reference

26 July 2017

Renee Doughman

14

1 reference

26 July 2017

Lori Backus

15

1 reference

26 July 2017

Lili Miles

16

1 reference

26 July 2017

Mariko DeWire

19

1 reference

26 July 2017

1 December 2015

1 reference

Journal of Neuro-Oncology

26 July 2017

1 reference

26 July 2017

127

1 reference

26 July 2017

1

1 reference

26 July 2017

53-61

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-015-2008-6

26 July 2017

0 references

cites work

High-grade gliomas in children

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Diffuse brainstem glioma in children: critical review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Advances toward an understanding of brainstem gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Angiogenesis in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

A randomized trial of bevacizumab for newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Brain stem tumors in children and adolescents: single institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Managing patients treated with bevacizumab combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Treatment of children with glioblastoma with conformal radiation, temozolomide, and bevacizumab as adjuncts to surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-2008-6

Expression of VEGF and its receptors in different brain tumors

21 January 2018

1 reference

12 December 2020

Correlation of clinical features and telomerase activity in human gliomas

1 reference

12 December 2020

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

1 reference

12 December 2020

Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study

1 reference

12 December 2020

Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma

1 reference

12 December 2020

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

1 reference

12 December 2020

Telomerase activity and hTERT mRNA expression in glial tumors.

1 reference

12 December 2020

10.1007/S11060-015-2008-6

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference